Figure 4.

Scatterplots depicting salivary estradiol and PANAS Negative Affect scores on the days surrounding delivery (i.e., day 0) in (A) high-risk women who developed PPD (n=4), (B) high-risk women who did not develop PPD (n=4), and (C) never-depressed control women (n=12). Scatterplots depicting salivary estradiol and PANAS Negative Affect scores in the same (D) high-risk women who developed PPD, (E) high risk women who did not develop PPD, and (F) never-depressed control women.